Spyre Therapeutics Inc (NAS:SYRE)
$ 87.38 +0.29 (+0.34%) Market Cap: 7.70 Bil Enterprise Value: 6.71 Bil PE Ratio: 0 PB Ratio: 8.06 GF Score: 26/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1